Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 2.5601
-1.91 %
$ 3.43 M
Market Cap
-2.59
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
25.11%
EBIT
Estimate
--15.82%
Net Income
Estimate
66.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sonoma Pharmaceuticals, Inc.
SNOA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SNOA
EBIT FORECAST
EBIT Forecast Chart SNOA
NET INCOME FORECAST
Net Income Chart SNOA